ruthenium has been researched along with tamoxifen in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Livshitz, T; Shani, J; Wenzel, M | 1 |
| Hillard, EA; Huché, M; Jaouen, G; Pigeon, P; Salomon, E; Top, S; Vessières, A | 1 |
| Aguiar, AC; Goulart, MO; Jaouen, G; Krettli, AU; Oliveira, AC; Pigeon, P; Souza, NB; Top, S | 1 |
| Du, J; Fan, J; Li, M; Peng, X; Sun, W; Zhao, X | 1 |
| Bohic, S; Bouron, A; Carriere, M; Cloetens, P; da Silva, JC; Fus, F; Jaouen, G; Lee, HZS; Pacureanu, A; Salmain, M; Top, S; Vessières, A; Yang, Y | 1 |
| Golding, TM; Mbaba, M; Smith, GS | 1 |
1 review(s) available for ruthenium and tamoxifen
| Article | Year |
|---|---|
Recent Advances in the Biological Investigation of Organometallic Platinum-Group Metal (Ir, Ru, Rh, Os, Pd, Pt) Complexes as Antimalarial Agents.
Topics: Amines; Aminoquinolines; Animals; Antimalarials; Benzimidazoles; Coordination Complexes; Ferrous Compounds; HEK293 Cells; Humans; Imidazoles; Iridium; Ligands; Malaria; Metallocenes; Molecular Structure; Organometallic Compounds; Osmium; Palladium; Platinum; Quinolines; Rhodium; Ruthenium; Salicylates; Silanes; Tamoxifen; Thiosemicarbazones | 2020 |
5 other study(ies) available for ruthenium and tamoxifen
| Article | Year |
|---|---|
Sex-dependent organ distribution of radiopharmaceuticals: effect of hormones on localization of acetyl-103Ru-ruthenocene.
Topics: Animals; Contraceptive Agents, Male; Cyproterone; Cyproterone Acetate; Estradiol; Female; Gonadal Steroid Hormones; Kidney; Kinetics; Liver; Male; Organ Specificity; Organometallic Compounds; Radioisotopes; Rats; Ruthenium; Sex Factors; Tamoxifen; Testosterone | 1985 |
Selective estrogen receptor modulators in the ruthenocene series. Synthesis and biological behavior.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Electrochemistry; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Female; Humans; Models, Molecular; Neoplasms, Hormone-Dependent; Organometallic Compounds; Ruthenium; Stereoisomerism; Structure-Activity Relationship; Tamoxifen | 2005 |
Antiplasmodial activity of iron(II) and ruthenium(II) organometallic complexes against Plasmodium falciparum blood parasites.
Topics: Animals; Antimalarials; Cell Line; Chromatography, Thin Layer; Coordination Complexes; Cytotoxins; Ferrous Compounds; Haplorhini; Hep G2 Cells; Humans; In Vitro Techniques; Inhibitory Concentration 50; Organometallic Compounds; Plasmodium falciparum; Ruthenium; Tamoxifen | 2015 |
An estrogen receptor targeted ruthenium complex as a two-photon photodynamic therapy agent for breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Death; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; MCF-7 Cells; Molecular Structure; Optical Imaging; Organometallic Compounds; Photochemotherapy; Photons; Photosensitizing Agents; Receptors, Estrogen; Ruthenium; Structure-Activity Relationship; Tamoxifen | 2018 |
Intracellular Localization of an Osmocenyl-Tamoxifen Derivative in Breast Cancer Cells Revealed by Synchrotron Radiation X-ray Fluorescence Nanoimaging.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Membrane; Coordination Complexes; Female; Humans; Hydrogen-Ion Concentration; Iron; Ligands; Molecular Imaging; Molecular Probes; Nanostructures; Organometallic Compounds; Osmium; Radiography; Ruthenium; Static Electricity; Synchrotrons; Tamoxifen; Triple Negative Breast Neoplasms; X-Rays | 2019 |